
RxSight
RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.
- 292
- Public
RxSight®, founded in Aliso Viejo, California, is dedicated to transforming the cataract surgery experience. The company's core mission is to revolutionize premium cataract surgery by offering the world's first and only adjustable intraocular lens (IOL) that can be customized post-surgery. Their flagship product, the Light Adjustable Lens™ (LAL®/LAL+™), along with the Light Delivery Device™ (LDD™) system, allows for precise vision adjustments after cataract surgery, catering to patients with corneal astigmatism and without preexisting macular disease.
Notable figures affiliated with RxSight include leading ophthalmologists and industry experts who have contributed to its innovative technology. The company has attracted significant investment from prominent venture capital firms, bolstering its research and development efforts. Key achievements include FDA approval of their adjustable IOL technology and successful commercialization of their products. RxSight's impact on the market is profound, offering a groundbreaking solution that enhances patient outcomes and sets a new standard in cataract surgery.
Similar Companies

Atia Vision
atiavision.com

Sight Sciences
sightsciences.com
ReaLens

Adaptilens
adaptilens.com

STAAR Surgical
staar.com

Clerio Vision
cleriovision.com
Elenza
elenza.com

Ovitz
ovitz.us

Visie
visievision.com

IrisVision
irisvision.com

Retina Technologies

Eyedaptic
eyedaptic.com

Synergeyes
synergeyes.com

Opticent Health
opticenthealth.com

MediPrint Ophthalmics
mediprintlens.com
Quick Facts
Who are RxSight's competitors?
Companies similar to RxSight include Atia Vision, Sight Sciences, ReaLens and Adaptilens.
When was RxSight founded?
RxSight was founded in 1997.
Where is RxSight's headquarters located?
RxSight's headquarters is located in Aliso Viejo, CA, US.
When was RxSight's last funding round?
RxSight's most recent funding round was for $50M (USD) in February 2023.
How much disclosed funding has RxSight raised?
As of Feb 7, 2023, RxSight has disclosed funding of $236M (USD). Undisclosed round amounts are excluded.
How many employees does RxSight have?
RxSight has 292 employees as of Feb 6, 2024.
Classification
- Industry
- Ownership
- Geographic Exposure
- Revenue
- Customer
- Main Product
- Tags
- Ticker
- RXST
- SEC CIK
- 0001111485
- EIN
- 94-3268801
- NAICS
- 339100Medical Equipment and Supplies Manufacturing
- 339110Medical Equipment and Supplies Manufacturing
- 339113Surgical Appliance and Supplies Manufacturing
- 330000Manufacturing
- 339000Miscellaneous Manufacturing
- SIC
- 3850Ophthalmic Goods
- 3851Ophthalmic Goods
- ISIC
- 3250Manufacture of medical and dental instruments and supplies
Show 15 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 339115Ophthalmic Goods Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- SIC
- 3900Miscellaneous Manufacturing Industries
- 4000Railroad Transportation
- 5000Wholesale Trade-durable Goods
- 8000Health Services
- 5040Professional And Commercial Equipment And Supplies
- 8040Offices And Clinics Of Other Health Practitioners
- 5047Medical, Dental, And Hospital Equipment And Supplies
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified